Oak Review

Oak's verdict: one flat price, no dose-creep penalty

Oak (run by Oak Longevity Holdings Corp.) is built around a single idea that most GLP-1 telehealth services don't honor: you pay one price no matter what dose you're on. For semaglutide that's $130 a month, every month, whether you're at a starter dose or have titrated all the way up. That alone makes it worth a look for anyone who has been burned by competitors that quietly raise the bill each time the clinician bumps your dose. It's a strong value play — but it's compounded-only, the pharmacy isn't named, and the fine print is unusually strict, so it isn't for everyone.

How the flat, all-dose pricing actually works

Most compounding telehealth pricing is tiered: the milligrams go up, and so does your monthly charge. Oak collapses that into a flat rate. Compounded semaglutide is $130 per month across all dose strengths, and compounded tirzepatide sits at a higher flat rate — but it too holds steady as you titrate. The homepage sums up the model in three words: one price, all dosages, no subscriptions. A first-month promo code (OAKNEW50) knocks the opening semaglutide month down to $80.

Why this matters in practice: GLP-1 dosing is designed to escalate over your first several months. On a tiered plan, the maintenance dose where the medication actually works best is also the most expensive. On Oak, your month-three bill looks exactly like your month-one bill. Against a category median of $169, the semaglutide rate is well below average — and it stays there.

• Free shipping is included, not an add-on at checkout.
• Free health coaching comes standard with the medication.
• No video call is required for initial approval — it's an asynchronous intake form.
• No subscription lock-in language on the marketing site, though note the refund policy below.

What Oak prescribes and how it reaches you

Oak offers exactly two medications: compounded semaglutide and compounded tirzepatide, both injectable. There is no oral version, and — importantly — no brand-name option. You will not get Wegovy, Ozempic, Zepbound, or Mounjaro here. Prescriptions are issued through NVP Medical Group, P.A., which operates as professional corporations in Florida, New York, New Jersey, Kansas, and California. After an online intake reviewed by a clinician, an approved prescription is filled by Oak's partner pharmacies and shipped to your door at no extra charge.

The real differentiator — and its honest catch

Oak's genuine edge is the no-markup-as-you-titrate model bundled with free shipping and coaching. For a long-term GLP-1 user, predictable pricing is the whole game, and few competitors guarantee it. But the standout catch is transparency: Oak refers to 'partner pharmacies' without naming them anywhere on the public site. For a medication you inject into your body, not knowing which compounding pharmacy fills it is a real disclosure gap. You can ask before committing — but you shouldn't have to dig.

Who should pick Oak — and who should walk

Oak is a good fit if you want compounded semaglutide or tirzepatide at the lowest stable price you can find, you're comfortable with an injection, and you'd rather skip a live video consult. The flat rate rewards people who plan to stay on therapy for the long haul and climb to a maintenance dose.

Skip Oak if you specifically want brand-name medication (it offers none), if you need an oral pill instead of an injection, or if naming your pharmacy upfront is a dealbreaker. Also weigh the fine print: fees are non-refundable in whole or in part per the Terms of Use, and disputes go to binding arbitration under Delaware law. If you like the option to get your money back when something doesn't work out, that's a meaningful tradeoff.

Trust, safety, and medical oversight

On the reassuring side: Oak carries a LegitScript certification in its footer, prescriptions run through a licensed medical group (NVP Medical Group, P.A.), and our check of the FDA warning-letter database turned up no warning letters or regulatory actions against Oak Longevity Holdings Corp. There's a real clinician-and-pharmacy structure behind it, not a storefront with no medical backing.

On the cautious side, we rate verification confidence as medium rather than high — and for specific, documented reasons. The pharmacy partners aren't publicly named. The company says it serves 45 states, but the actual state list is gated behind the signup intake instead of published, so we can't confirm coverage before you start an application. And the medication is compounded, not FDA-approved brand product, which is legal and common in this space but carries a different oversight profile than an approved drug. None of these are red flags on their own; together they're why Oak earns a solid-but-not-top trust score. See our scoring methodology for how we weigh these factors.

Bottom line

Oak does one thing unusually well: it removes the dose-creep penalty that makes other compounded GLP-1 plans get pricier exactly when they start working. At $130 a month flat for semaglutide — $80 your first month with OAKNEW50, against a $169 category median — with free shipping and coaching thrown in, the value is genuine. Just go in clear-eyed: it's compounded and injectable only, the pharmacy isn't named, and the no-refund, arbitration-only terms are stricter than most. If those tradeoffs are acceptable, Oak is one of the better flat-rate deals in the category.